EW News and Press, Edwards Lifesciences Corporation From 09/12/22

EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL PR Newswire IRVINE, Calif. , Sept. 12, 2022 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' br...

Summary Bridgewater Associates’ 13F portfolio value decreased from ~$24.81B to ~$23.60B this quarter. They increased Walmart and CVS Health while dropping Alibaba and JD.com. The top three individual stock positions are Procter & Gamble, Johnson & Johnson, and C...

EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK PR Newswire IRVINE, Calif. , Aug. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), today announced the company's PASCAL Precision transca...

On August 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q2 2022. I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. June was a temporary bottom in the marke...

Momentum's shift into the Health Care sector proved ill-timed last May. Edwards Lifesciences has outperformed lately, but shares are not cheap, and the technical picture is somewhat bearish. An upcoming conference could spark share price volatility. The momentum factor w...

Fisher’s 13F portfolio value decreased from ~$165B to ~$141B in Q2 2022. Johnson & Johnson and Capital One Financial were increased while reducing Eli Lilly and Novo Nordisk this quarter. The top three positions are Apple, Microsoft, and Amazon. They add up to ~15% of t...

Analysis of the top ten pharma and medical device companies shows a 2% advantage for medical device on a total return basis over the last ten years. There are many possible reasons for this difference but patent cliffs and litigation are problems for Pharma. Investors seeking supe...

Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...

Image source: The Motley Fool. Edwards Lifesciences (NYSE: EW) Q2 2022 Earnings Call Jul 28, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Edwards Lifesciences (EW) Q2 2022 Earnings Call Transcript

Edwards Lifesciences Corporation (EW) Q2 2022 Earnings Conference Call July 28, 2022, 05:00 PM ET Company Participants Mark Wilterding - VP, IR and Treasurer Mike Mussallem - Chairman and CEO Scott Ullem - CFO Larry Wood - Global Leader, TAVR Bernard Zovi...